$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
DeepCurrents Investment Group LLC Buys Jazz Pharmaceuticals PLC, S&P 500 ETF TRUST ETF, ...
04:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: SPY , ON , JAZZ , EXPE , GM , FDX , NICE , JAMF , CNMD , VIAV , PLUG , BKNG , EEFT , RDFN , MTN , BABA , VNET , SRNGU , RMGB ,
Intrathecal Drug Market to Eyewitness Stunning Growth by 2027 | Saol Therapeutics, Jazz Pharmaceuticals
09:23am, Tuesday, 16'th Nov 2021 OpenPR
This Intrathecal Drug market report also focuses on a few key projections that are necessary for a positive business future. New technologies are also presented in order to gain a total advantage over the competition. Numerous industry aspects, including sales
Point72 Asset Management Buys International Business Machines Corp, Activision Blizzard Inc, ...
12:38am, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: TWTR , TMO , SRPT , EA , GM , MSFT , IBM , ATVI , WLTW , JAZZ , JNPR , DTM , MU , FIVN , REGN , CSCO , BABA , NFLX ,
Premier Asset Management Llc Buys iShares Russell 2000 ETF, Palo Alto Networks Inc, General ...
08:38pm, Monday, 15'th Nov 2021 GuruFocus
Related Stocks: IWM , VZ , ABB , ENPH , ABBV , UPS , PANW , GE , XLNX , BAC , CVX , STLD , COUP , XOM , JAZZ , GLW , GBT , TU ,
Going Long On Top Marijuana Stocks To Buy? 3 Of The Best Cannabis Stocks To Watch Right Now
10:00am, Sunday, 14'th Nov 2021
These Marijuana Stocks Could Be Ways To Invest In Cannabis Long Term The post Going Long On Top Marijuana Stocks To Buy? 3 Of The Best Cannabis Stocks To Watch Right Now appeared first on Marijuana St
Score might not show it, but Jazz blasted by Heat
12:55am, Sunday, 14'th Nov 2021 KSL
A late surge wasn''t enough to hide this: Utah is officially in a slump.And from the looks of Saturday''s 111-105 loss to Miami, it might be a pretty bad one.
Instant analysis: Jazz late rally not enough to make up for bad performance against the Heat
12:49am, Sunday, 14'th Nov 2021 Deseret
Utah Jazz guard Mike Conley (11) drives against Miami Heat center Bam Adebayo (13) during the game at Vivint Arena in Salt Lake City on Saturday, Nov. 13, 2021. | Spenser Heaps, Deseret News The Utah Jazz mounted a late fourth-quarter rally at Vivint Arena on Saturday, but it was too little, too late against the Miami Heat. The Jazz lost, 111-105, and fell to 8-5 on the season High Notes The Jazz were playing very, very poorly, and it was looking like they might not even get double digits on the scoreboard before the first quarter was over. Well, Jordan Clarkson wasnt going to have that. He scored 14 of the Jazzs final 17 points of the quarter in a span of less than four minutes. He was absolutely the only reason the Jazz werent being blown out by the start of the second period. Donovan Mitchells defense deserves some praise. There was a play midway through the first quarter when the Heat were running in transition with a 3-on-1 chance and Mitchell was the only one standing in their way.
This Week's Slew of Cannabis Earnings and Breaking News
02:59pm, Friday, 12'th Nov 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to sha
Jazz Pharma (JAZZ) Q3 Earnings Beat, New Drugs Drive Sales
10:43am, Wednesday, 10'th Nov 2021
Jazz Pharma's (JAZZ) product revenues grow in the third quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals.
Jazz Pharmaceuticals PLC (JAZZ) CEO Bruce Cozadd on Q3 2021 Results - Earnings Call Transcript
11:22pm, Tuesday, 09'th Nov 2021
Jazz Pharmaceuticals PLC (JAZZ) CEO Bruce Cozadd on Q3 2021 Results - Earnings Call Transcript
Jazz Pharmaceuticals (JAZZ) Tops Q3 Earnings and Revenue Estimates
08:35pm, Tuesday, 09'th Nov 2021
Jazz (JAZZ) delivered earnings and revenue surprises of 28.44% and 0.98%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
05:56pm, Tuesday, 09'th Nov 2021
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharmaceutical company, announced its financial results Tuesday afternoon for the third quarter of 2021 and updated financial guidance for 2021.
Jazz Pharmaceuticals: Q3 Earnings Insights
04:33pm, Tuesday, 09'th Nov 2021
Jazz Pharmaceuticals (NASDAQ: JAZZ) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.
Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences
04:15pm, Tuesday, 09'th Nov 2021
DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will virtually participate in the following upcoming investor conferences: Jefferies Lon
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across Hematology/Oncology at ASH 2021 Annual Meeting
11:04am, Thursday, 04'th Nov 2021
DUBLIN, Nov. 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will be presented at t
Sign In
Buy JAZZ